Avadel Pharmaceuticals adds director
Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds
Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall
Global M&A By the Numbers: Q1 2022
Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes
Avadel Pharmaceuticals plc has appointed Kevin Kotler to the board, effective Dec. 11.
Kotler is the founder and portfolio manager of Broadfin Capital LLC and a director of BioDelivery Sciences International Inc.
Dublin-based Avadel Pharmaceuticals develops and commercializes pharmaceutical products primarily for treating urology and sleep medicines.